Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Adaptin Bio, Inc. (APTN) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Adaptin Bio, Inc. (APTN), most recent 12 months reported: net loss $5.4M. Latest balance sheet on file: liquid cash $670.49K. From SEC filings. Others in Biological Products, (No Diagnostic Substances): Acumen Pharmaceuticals, Inc. · Abpro Holdings, Inc. · AGENTIX CORP. · Allogene Therapeutics, Inc. · ARMATA PHARMACEUTICALS, INC. · Artiva Biotherapeutics, Inc. · Aura Biosciences, Inc. · ANAVEX LIFE SCIENCES CORP.

Stock screener

Watchlist